Dynavax Technologies
Biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Launch date
Employees
Market cap
€1.3b
Enterprise valuation
€866m (Public information from Sep 2024)
Share price
$11.5 DVAX
Berkeley California (HQ)
Authorizing premium user...